Familial ATTR-PN
Showing 1 - 25 of 1,285
Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy,
Recruiting
- Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
- +2 more
- NTLA-2001
-
Paris, France
- +3 more
Nov 29, 2022
Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy Trial (Acoramidis)
Withdrawn
- Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
- (no location specified)
Jan 26, 2022
Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy Trial in San Francisco (AG10, Placebo)
Withdrawn
- Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
- AG10
- Placebo
-
San Francisco, CaliforniaEidos Therapeutics
Jun 11, 2021
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy Trial (NTLA-2001, Placebo)
Not yet recruiting
- Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
- NTLA-2001
- Placebo
- (no location specified)
Nov 8, 2023
Amyloidosis, Hereditary Trial in Richmond (Registry)
Not yet recruiting
- Amyloidosis, Hereditary
- Registry
-
Richmond, VirginiaVirginia Commonwealth University
Jul 25, 2023
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Not yet recruiting
- Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
- +2 more
-
Auckland, New Zealand
- +2 more
Jan 24, 2023
Transthyretin Amyloid Polyneuropathy (ATTR-PN) Trial in China (tafamidis meglumine)
Active, not recruiting
- Transthyretin Amyloid Polyneuropathy (ATTR-PN)
- tafamidis meglumine
-
Beijing, Beijing, China
- +7 more
Nov 21, 2022
Hereditary Transthyretin Amyloidosis Patients Included in
Completed
- Hereditary Transthyretin Amyloidosis (ATTRv)
- Polyneuropathy
-
Barcelona, Spain
- +2 more
Dec 23, 2022
Transthyretin Amyloidosis, Heart Failure, Heart Failure, Diastolic Trial in Boston (99mTc-pyrophosphate Scintigraphy)
Recruiting
- Transthyretin Amyloidosis
- +3 more
- 99mTc-pyrophosphate Scintigraphy
-
Boston, MassachusettsMassachusetts General Hospital
Oct 11, 2022
Transthyretin Amyloidosis in Left Ventricular Hypertrophy of
Completed
- Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
- Diagnosis of TTR amyloidosis cardiomyopathy
-
Chermside, Australia
- +17 more
Nov 3, 2022
Hereditary Transthyretin Amyloidosis With Polyneuropthy Trial in Canada, United States (Blood samples for immunoglobulins, Blood
Recruiting
- Hereditary Transthyretin Amyloidosis With Polyneuropthy
- Blood samples for immunoglobulins
- +2 more
-
Rosedale, New York
- +3 more
Dec 19, 2022
Prospective Evaluation of NfL as a Biomarker in ATTRv
Not yet recruiting
- Amyloidosis, Hereditary
- (no location specified)
May 18, 2023
Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR
Not yet recruiting
- Amyloidosis, Hereditary
- +4 more
-
New York, New York
- +2 more
Aug 3, 2022
Study of Patients With hATTR-PN
Recruiting
- Hereditary Transthyretin Amyloidosis With Polyneuropthy
- Data Collection
-
Anchorage, Alaska
- +22 more
Feb 1, 2023
Lumbar Spine Stenosis Specimens for Identification of
Not yet recruiting
- Lumbar Spinal Stenosis
- +5 more
- Tc99-PYP or Tc99-HDMP Scan
-
Beverly Hills, California
- +5 more
Sep 12, 2023
Familial ATTR-CM (ATTRm-CM, or FAC) and Wild-type ATTR-CM (ATTRwt-CM) Trial in United States (AG10, Placebo Oral Tablet)
Completed
- Familial ATTR-CM (ATTRm-CM, or FAC)
- Wild-type ATTR-CM (ATTRwt-CM)
- AG10
- Placebo Oral Tablet
-
Beverly Hills, California
- +12 more
Oct 24, 2022
Familial Amyloidotic Polyneuropathy (BioTRAP)
Completed
- Transthyretin Amyloidosis
- +2 more
-
Rostock, Germany
- +1 more
May 4, 2021
Mitral Regurgitation, ATTR-Cardiomyopathy, Edge-to-Edge Mitral Valve Repair Trial (TEER, Optimal Medical Therapy)
Not yet recruiting
- Mitral Regurgitation
- +2 more
- TEER
- Optimal Medical Therapy
- (no location specified)
Oct 4, 2023
Transthyretin Amyloidosis Trial in New York (I 124-Evuzamitide)
Recruiting
- Transthyretin Amyloidosis
- I 124-Evuzamitide
-
New York, New YorkColumbia University Irving Medical Center
Nov 23, 2022
Aortic Stenosis and Cardiac Amyloidosis
Recruiting
- Cardiac Amyloidosis
- Aortic Stenosis
- Amyloid-specific treatment
- No amyloid-specific treatment
-
Vienna, Austria
- +1 more
Nov 8, 2023
Study of Transthyretin-Mediated Amyloidosis
Recruiting
- Transthyretin-Mediated Amyloidosis
- ATTR Amyloidosis
-
La Jolla, California
- +23 more
Jan 13, 2023
Hereditary Transthyretin Amyloidosis
Recruiting
- Amyloidosis
- +6 more
-
Cleveland, OhioCleveland Clinic
Mar 11, 2022
Cardiomyopathies, Primary Trial ((18F)Flutemetamol)
Recruiting
- Cardiomyopathies, Primary
-
New Haven, ConnecticutYale University
Oct 11, 2022
Transthyretin Amyloidosis Trial in Beijin (Tafamidis Pill)
Recruiting
- Transthyretin Amyloidosis
- Tafamidis Pill
-
Beijin, ChinaPeking University Third Hospital
Jul 7, 2021